PLIANT THERAPEUTICS, INC. Earnings Per Share (Basic)
PLIANT THERAPEUTICS, INC. (PLRX) reported Earnings Per Share (Basic) of -$0.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.36.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.32.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.43.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.71.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$2.43.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$3.47.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$2.75.
- PLIANT THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.94.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.36 10-Q · filed 2026-08-11 | -$0.69 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | -$0.32 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$2.43 10-K · filed 2026-03-11 | |||
| 2025-09-30 | -$0.43 10-Q · filed 2025-11-06 | -$2.05 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.71 10-Q · filed 2026-08-11 | -$1.62 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | -$0.92 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | -$3.47 10-K · filed 2026-03-11 | |||
| 2024-09-30 | -$0.95 10-Q · filed 2025-11-06 | -$2.66 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.92 10-Q · filed 2025-08-07 | -$1.71 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.78 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$2.75 10-K · filed 2025-03-03 | |||
| 2023-09-30 | -$0.70 10-Q · filed 2024-11-07 | -$1.39 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.06 10-Q · filed 2024-11-07 | -$2.78 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-06-30 | -$0.70 10-Q · filed 2024-08-07 | -$1.37 10-Q · filed 2024-08-07 | -$2.08 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.74 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-03-31 | -$0.67 10-Q · filed 2024-05-06 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.04 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.83 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2022-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.17 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.94 10-K · filed 2025-03-03 |
| 2022-09-30 | -$0.65 10-Q · filed 2023-11-09 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.22 10-Q · filed 2023-11-09 | -$2.91 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | -$0.82 10-Q · filed 2023-08-09 | -$1.59 10-Q · filed 2023-08-09 | -$2.28 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$3.03 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | -$0.78 10-Q · filed 2023-05-09 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.21 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.85 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.43 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.07 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.71 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.75 10-Q · filed 2022-11-08 | -$1.39 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.03 10-Q · filed 2022-11-08 | -$2.57 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-06-30 | -$0.64 10-Q · filed 2022-08-08 | -$1.28 10-Q · filed 2022-08-08 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$2.28 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2021-03-31 | -$0.64 10-Q · filed 2022-05-09 | -$1.18 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$1.64 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$2.54 derived: net income ÷ weighted average shares · filed 2022-05-09 |
| 2020-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.89 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.95 10-K · filed 2022-03-01 |
| 2020-09-30 | -$0.47 10-Q · filed 2021-11-09 | -$1.41 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$1.36 10-Q · filed 2021-11-09 | $0.50 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-06-30 | -$1.39 10-Q · filed 2021-08-09 | -$0.85 10-Q · filed 2021-08-09 | $4.33 derived: net income ÷ weighted average shares · filed 2022-03-01 | $1.90 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $21.59 derived: net income ÷ weighted average shares · filed 2022-03-01 | $14.05 derived: net income ÷ weighted average shares · filed 2022-03-01 | $4.88 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2019-12-31 | $22.12 derived: net income ÷ weighted average shares · filed 2022-03-01 | $14.41 derived: net income ÷ weighted average shares · filed 2022-03-01 | $5.02 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$4.22 10-K · filed 2022-03-01 |
| 2019-09-30 | -$8.53 10-Q · filed 2020-11-10 | -$19.25 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$30.03 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$10.82 10-Q · filed 2020-08-11 | -$21.70 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |